首页> 美国卫生研究院文献>other >Z-Group ketone chain transfer agents for RAFT polymer nanoparticle modification via hydrazone conjugation
【2h】

Z-Group ketone chain transfer agents for RAFT polymer nanoparticle modification via hydrazone conjugation

机译:用于RaFT聚合物纳米颗粒修饰通过腙共轭Z-组酮链转移剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A ketal-containing trithiocarbonyl compound has been synthesized and characterized as a chain transfer agent (CTA) in Reversible Addition Fragmentation Transfer (RAFT) polymerization. The ketal functionality does not interfere with RAFT polymerization of acrylate monomers, which proceeds as previously reported to yield macro-CTA polymers and block co-polymers. Post-polymerization ketal cleavage revealed ketone functionality at the polar terminus of an amphiphilic block co-polymer. Hydrazone-formation was facile in both organic solution as well as in aqueous buffer where polymer nanoparticle assemblies were formed, indicating a conjugation/end-functionalization yield of 40–50%. Conjugation was verified with fluorescein, biotin and Gd-DOTA derivatives, and though the trithiocarbonate linkage is hydrolytically labile, we observed stable conjugation for several days at pH 7.4. and 37°C. As expected, streptavidin binding to biotinylated polymer micelles was observed, and size-change based relaxivity increases were observed when Gd-DOTA hydrazide was conjugated to polymer micelles. Cell-uptake of fluorescently labeled polymer micelles was also readily tracked by FACS and fluorescence microscopy. These polymer derivatives demonstrate a range of potential theranostic/biotechnological applications for this conveniently accessible keto-CTA, which include ligand-based nanoparticle targeting and fluorescent/MR nanoparticle contrast agents.
机译:已合成了含缩酮的三硫羰基化合物,并将其表征为可逆加成片段转移(RAFT)聚合中的链转移剂(CTA)。缩酮官能团不会干扰丙烯酸酯单体的RAFT聚合,丙烯酸酯单体的聚合反应如先前报道的那样进行,可生成大分子CTA聚合物和嵌段共聚物。聚合后的缩酮裂解显示出两亲嵌段共聚物极性末端的酮官能团。在有机溶液以及形成聚合物纳米粒子组件的水性缓冲液中,的形成都很容易,这表明偶联/末端官能化的收率为40–50%。用荧光素,生物素和Gd-DOTA衍生物证实了结合,尽管三硫代碳酸酯键水解不稳定,但我们在pH 7.4下观察到了稳定的结合数天。和37°C。如所预期的,观察到链霉亲和素与生物素化的聚合物胶束的结合,并且当将Gd-DOTA酰肼缀合至聚合物胶束时,观察到基于尺寸变化的弛豫性增加。荧光标记的聚合物胶束的细胞摄取也很容易通过FACS和荧光显微镜进行追踪。这些聚合物衍生物证明了这种方便获得的酮-CTA的一系列治疗学/生物技术应用前景,包括基于配体的纳米粒子靶向和荧光/ MR纳米粒子造影剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号